PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance
Guildford, UK 14th June, 2017
Alexion secures ex-Biogen Chief Financial Officer
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment
Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …
Bhutan and Maldives successfully eliminate measles
June 14, 2017Medical Communications, Research and Development WHO, immunisation, measles, rubella
The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …
Celltrion biosimilar proves effectiveness in lymphoma and rheumatoid arthritis
June 14, 2017Research and Development Cellltrion, Truxima, biosimilar, lymphoma, rheumatoid arthritis, rutiximab
Celltrion Healthcare has revealed new data which validates its biosimilar Truxima (CT-P10) as non-inferior to its reference product rituximab in …
Reversal of type 1 diabetes possible through century-old vaccine
June 14, 2017Research and Development BCG, Type 1 diabetes, Vaccine, diabetes
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …
FDA to review effectiveness of abuse deterrent opioid drugs
June 14, 2017Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid, opioid crisis
FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …
Genetic test reveals at-risk men for testicular cancer
June 14, 2017Research and Development ICR, Movember Foundation, testicular cancer
Research emerging from the Institute of Cancer Research has revealed the men most statistically at-risk of developing testicular cancer. The …
BMS vet joins Kleo Therapeutics as CEO
June 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Kleo Pharmaceutical
Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …
MSD forced to pause enrolment after Keytruda deaths
June 13, 2017Manufacturing and Production, Research and Development
MSD has been hit by a major surprise after an independent monitoring committee raised a warning after an imbalance in …
Prescription costs vary wildly between high-income countries
June 13, 2017Manufacturing and Production, Sales and Marketing medicine, prescription, prescription cost
A study originating out of Canada has laid bare the difference in cost of primary care prescription drugs between different …
Sun Pharma rises again with FDA cholesterol drug approval
June 13, 2017Manufacturing and Production Sun Pharma
Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …
FDA approves BioMarin’s Irish facility
June 13, 2017Manufacturing and Production BioMarin, Ireland, cork, vimizin
The FDA has approved BioMarin’s bulk biologic manufacturing plant, based in Cork, Ireland. The facility will manufacture an ingredient of …
SMC reverses decision on Opdivo for kidney cancer
June 12, 2017Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, SMC, opdivo
The Scottish Medicines Consortium (SMC) has performed a U-turn on its decision regarding Opdivo (nivolumab), and will now allow patients …
European Medicines Agency: Staying consistent in a turbulent time
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit
With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …
FlyPharma Conference 2017 – “Collaboration is the key”
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FlyPharma conference, PHARMA SUPPLY CHAIN, flypharma, supply chain
As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …
Type 2 diabetes directly linked to BMI
June 12, 2017Research and Development, Sales and Marketing diabetes, type 2 diabetes
Research emerging from the American Diabetes Association’s meeting in San Diego has revealed that the likelihood of developing type 2 …
Teva conducts boardroom shuffle with four new faces
June 12, 2017Medical Communications, Sales and Marketing
It is well-known that Teva Pharmaceutical has had a rough time of late, particularly in terms of employees. It has …
Sanofi and Regeneron posts positive Praluent cholesterol data
June 12, 2017Research and Development, Sales and Marketing Regeneron, Sanofi, praluent
Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …
AbbVie loses $15 million Depakote birth-defect case
June 12, 2017Sales and Marketing AbbVie, Abbott, Depakote
Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …
High potency drugs – from molecule to market
June 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI
To print or download a PDF version of this article, click here.
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
